Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

283
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
283
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

172
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
172
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dihomo-γ-Linolenic Acid Elevation with Desaturase Imbalance in Metabolic Dysfunction-Associated Steatotic Liver Disease in a Japanese Health Checkups Cohort: HOZUGAWA Study, a Multi-Omic, Diet Adjusted Analysis.

Nutrients·2026
Same author

Efficacy of combined use of magnifying narrow-band imaging/blue laser imaging and Lugol chromoendoscopy for tumor extent delineation in esophageal squamous cell carcinoma.

Esophagus : official journal of the Japan Esophageal Society·2026
Same author

Dynamic Changes in Fourth Heart Sound in Type 2 Diabetes: Insights From Visualized Phonocardiography and SGLT2 Inhibitor Adjustment.

Case reports in medicine·2025
Same author

Safety and Feasibility of Intensive Downstaging Polypectomy With Low-Power Pure-Cut Hot Snare Polypectomy in Patients With Familial Adenomatous Polyposis (With Video).

Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society·2025
Same author

Editorial for the Special Issue "Advances in Clinical Diabetes, Obesity, and Metabolic Diseases".

Medicina (Kaunas, Lithuania)·2025
Same author

B-type natriuretic peptide efficacy compared to fragmented QRS for diastolic dysfunction screening in patients with type 2 diabetes.

World journal of diabetes·2025

Related Experiment Video

Updated: Jul 2, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K

Improved Glycemic Control through Robot-Assisted Remote Interview for Outpatients with Type 2 Diabetes: A Pilot

Kunimasa Yagi1,2, Michiko Inagaki3, Yuya Asada3

  • 1Department of Internal Medicine, Kanazawa Medical University Hospital, Ishikawa 920-0293, Japan.

Medicina (Kaunas, Lithuania)
|February 24, 2024
PubMed
Summary

Robot-assisted monitoring improved glycemic control in type 2 diabetes patients. Focusing on conversational content, not just naturalness, enhances system effectiveness for better diabetes management.

Keywords:
RoBoHoNcertified diabetes care and education specialistsdiabetes self-managementinformation and communication technologyrobottype 2 diabetes

More Related Videos

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.6K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.3K

Related Experiment Videos

Last Updated: Jul 2, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.8K
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

11.6K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.3K

Area of Science:

  • Biomedical Engineering
  • Health Informatics
  • Endocrinology

Background:

  • A novel robot-assisted system was developed to aid Certified Diabetes Care and Education Specialists (CDCESs) in monitoring patients with type 2 diabetes (T2D).
  • The system aims to support remote tracking of patient health status.

Purpose of the Study:

  • To evaluate the impact of the robot-assisted system on glycemic control in patients with T2D.
  • To identify patient characteristics suitable for utilizing this technology.

Main Methods:

  • Remote interviews were conducted with T2D patients using the RoBoHoN robot after obtaining informed consent.
  • Glycemic control was assessed via HbA1c levels at baseline and two months post-interview.
  • Patients were categorized based on HbA1c targets; those with medication changes were excluded.

Main Results:

  • Of 28 eligible patients, 8 improved glycemic control (1 inadequate to adequate, 7 inadequate to adequate).
  • Multiple regression analysis indicated that clarity and naturalness of robot responses significantly contributed to glycemic control status.
  • Focusing on conversational content, rather than superficial naturalness, is suggested for future system improvements.

Conclusions:

  • The robot-assisted diabetes management system demonstrated efficacy in improving glycemic control.
  • The study highlights the potential of technology in supporting diabetes self-management and patient care.